TipRanks
Advertisement
Advertisement
LongBio Pharma Calls September 2026 EGM to Approve New Non-Executive Director
PremiumCompany AnnouncementsLongBio Pharma Calls September 2026 EGM to Approve New Non-Executive Director
2M ago
LongBio Pharma Advances Key Immunology Pipeline as Interim Loss Widens
Premium
Company Announcements
LongBio Pharma Advances Key Immunology Pipeline as Interim Loss Widens
2M ago
LongBio Pharma’s LP-003 Allergy Biologic BLA Accepted by China’s NMPA
Premium
Company Announcements
LongBio Pharma’s LP-003 Allergy Biologic BLA Accepted by China’s NMPA
2M ago
LongBio Pharma shareholders approve 2025 results, dividends and new capital mandates
PremiumCompany AnnouncementsLongBio Pharma shareholders approve 2025 results, dividends and new capital mandates
3M ago
LongBio Pharma Fully Exercises Over-Allotment Option to Raise HK$194.3 Million
Premium
Company Announcements
LongBio Pharma Fully Exercises Over-Allotment Option to Raise HK$194.3 Million
3M ago
LongBio Pharma’s LP-003 Hits Phase III Goals in Seasonal Allergic Rhinitis
Premium
Company Announcements
LongBio Pharma’s LP-003 Hits Phase III Goals in Seasonal Allergic Rhinitis
4M ago
LongBio Pharma Sets 2025 AGM to Decide Profit Distribution and Capital Mandates
PremiumCompany AnnouncementsLongBio Pharma Sets 2025 AGM to Decide Profit Distribution and Capital Mandates
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―